ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable has announced that teams at Bristol Myers Squibb and Merck & Co. have won its 2023 Peter J. Dunn Award for Green Chemistry and Engineering Impact and that PharmaBlock Sciences has won its 2023 Contract Manufacturing Organization (CMO) Excellence in Green Chemistry Award.
The Bristol Myers Squibb team is recognized for developing an enzymatic route to install two stereocenters on the cyclohexyl ring of BMS-986278, a lysophosphatidic acid receptor 1 antagonist in clinical trials as a treatment for lung fibrosis.
The Merck & Co. team is recognized for developing new organo- and bio-catalysis bond-forming strategies to the cyclic dinucleotide MK-1454, a stimulator of interferon genes agonist in clinical trials as a treatment for solid cancers and lymphomas.
PharmaBlock Sciences is recognized for an innovative continuous manufacturing process for 3-oxo cyclobutane-1-carboxylic acid, an intermediate used in several marketed drugs and drug candidates.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X